Citius Pharmaceuticals Aktie

Citius Pharmaceuticals für 0 Euro bei ZERO ordern (zzgl. Spreads)

WKN DE: A2DXS0 / ISIN: US17322U2078

<
Kurse + Charts + Realtime
Kurs + Chart
Times + Sales
Börsenplätze
>
<
News + Analysen
News + Adhoc
Analysen
Kursziele
>
<
Unternehmen
Termine
Profil
>
<
zugeh. Wertpapiere
Zertifikate
Optionsscheine
Knock-Outs
>
10.06.2025 13:30:41

Citius Pharma Announces Direct Offering

(RTTNews) - Citius Pharmaceuticals Inc. (CTXR) has entered into definitive agreements for the purchase of an aggregate of 4.92 million shares of its common stock and accompanying short-term warrants to purchase up to an aggregate of 9.84 million shares of its common stock, at a purchase price of $1.22 per share and accompanying short-term warrant in a registered direct offering priced at-the-market under Nasdaq rules. The short-term warrants will have an exercise price of $1.00 per share, will be exercisable immediately upon issuance, and will expire twenty-four months from the initial exercise date. The closing of the offering is expected to occur on or about June 11, 2025.

The aggregate gross proceeds to the company are expected to be approximately $6 million. The potential additional gross proceeds from the short-term warrants, if fully-exercised on a cash basis, will be approximately $9.8 million.

For More Such Health News, visit rttnews.com.

Nachrichten zu Citius Pharmaceuticals Inc Registered Shsmehr Nachrichten

Keine Nachrichten verfügbar.

Analysen zu Citius Pharmaceuticals Inc Registered Shsmehr Analysen

Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!